Company intelligence / Profile preview

Invitrox

Durham, North Carolina, United Statesinvitrox.com ↗

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Invitrox specializes in advanced, GLP-compliant bioanalytical and diagnostic testing services, with a focus on developing proprietary platforms such as EQELSTM to deliver high-specificity and high-sensitivity assays. The company supports non-clinical and clinical programs for clients across the life sciences sector. No clinical trial results or marketed products are reported as of 2025.

Therapeutic areas: Other
Modalities: Diagnostic assayTherapeutic assay
Industry: Contract Research Organization

Beyond the preview

Go deeper on Invitrox.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invitrox.

Explore the full profile